At the same time, waste products are ushered out of tissues more efficiently
Featuring a blend of essential nutrients, including Methionine, Inositol, Choline and Cyanocobalamin, MICC targets the efficient breakdown of fats and sugars, leading to improved energy conversion
Implications of GLP-1 receptor agonist on thyroid function: a literature review of its effects on thyroid volume, risk of cancer, functionality and TSH levels
GLP-1s are not casual wellness products
Boehringer Ingelheim International GmbH Key Target Audience Market Players Investors End-users Government Authorities Consulting And Research Firm Venture capitalists Value-Added Resellers (VARs) Recent Development In March 2023, the NHS approved Wegovy, a weight reduction injectable that mimics the hormone glucagon-like peptide-1 (GLP-1) and inhibits hunger
One such study with semaglutide (generic drug name for Wegovy) found that on discontinuation of the medication, patients regained about two-thirds of their prior weight loss in just a year.* 2/3 of lost weight regained within one year of stopping semaglutide 2/3 of lost weight regained within one year of stopping semaglutide A similar study tested deprescribing of tirzepatide (generic drug name for Zepbound)
